portance in the treatment of a range of human malignancies1}. However, their use is associated with a number of undesirable effects, the most serious being a dose-dependent cumulative cardiotoxicity.
To improve the chemotherapeutic efficiency of the drugs, a broad program of analog synthesis has been undertaken. Amongthe daunorubicin modifications, changes at the amino group appeared to modify the biological properties to the greatest extent2). It has been concluded that the retention of activity of such derivatives requires the nitrogen atom to have a basic character. Therefore iV-alkyl derivatives are of interest3~5).
This paper describes the synthesis of new compounds belonging to this class and obtained via nucleophilic addition of daunorubicin amino group to the active double bond of iV-substituted maleimides. The latter substances, with the most popular representative iV-ethylmaleimide, are used in biochemical experiments for modification of sulfhydryl-containing bioactive molecules under mild reaction conditions6>7). They have also been shown to react with amino groups and form the corresponding addition products6).
Synthesis of iV-alkyl derivatives of daunorubicin is presented in Chart 1. In a typical synthesis, 0.056 ml of triethylamine was added with stirring to a cooled solution of daunorubicin hydrochloride (225 mg, 0.4 mmol) in DMF(2.5 ml). Then, 7V-ethylmaleimide (300 mg, 2.4 mmol) was added in 3 portions within 5 hours and the reaction allowed to proceed at room temp for 24 hours. To the resulting solution H2O(10 ml) was added and the product extracted with EtOAc (2 x 100 ml). The separated organic layer was washed twice with H2O(10 ml), Chart 1. Yield (%) Activity against murine L1210 leukemia in tissue culture. Cells were maintained in RPMI-1640 medium supplemented with 5 % fetal calf serum, penicillin (100 u/ml) and streptomycin (100 /*g/ml) at 37°C in a controlled humid atmosphere of 5% CO2-95%air. EC50 values were determined after 48 hours of incubation of cells with tested compounds8). For comparison, EC50 value obtained for daunorubicin hydrochloride was 0.02±0.002 /ig/ml. (Meandb MSD). dried and evaporated in vacuo. The residue dissolved in CHCI3was subjected to column chromatography on silica gel and eluted with a mixture of CHCI3-MeOH(50 : 1) to give the free base of Ar-(A/r/-ethylsuccinimido)daunorubicin.
The compound was dissolved in CHC13(5 ml) and Et2O (70ml) saturated with HC1 was added.
The resultant precipitate was separated by centrifugation, washed with Et2O and dried to give 1 (227mg, 87%) ( Table  1 ). The other derivatives were obtained in a similar manner. The exception was compound 5, which was extracted from the reaction mixture with 1-butanol and purified by gel filtration on Sephadex LH-20 in MeOH.
Yields, physico-chemical and biological properties and XHNMRdata for daunorubicin derivatives obtained are given in Tables 1 and 2, respectively. Additional confirmation of the structures assumed was obtained from examination of the synthesized compounds using negative ion fast atom bombardment mass spectrometry (FAB-MS).
In all the cases, including the parent antibiotic, the abundant ion at m/z 380 (MT-aminosugar) was observed indicating the presence of unchanged aglycone and modified aminosugar moiety in the derivatives examined.
In the daunorubicin JV-alkylation reaction a new asymmetric center is formed as a result of the addition of the amino group to the olefinic double bond of^-substituted maleimide. The analysis of appropriate signals (methine protons on the dioxopyrrolidine ring and anomeric protons) showed the presence of the corresponding diastereoisomers in a ratio of 1 : 1. Although retain the basic character of a modified daunosamine amino group, the synthesized compoundsgenerally exhibit decreased cytotoxic activity, compared to that of daunorubicin (Table 1 ). This activity is strongly dependent on the alkyl (R) substituent.
The reaction product of daunorubicin with maleimide bearing small alkyl group at nitrogen atom (compound 1) exhibits quite good activity. Replacement of the ethyl group by a bulky substituent (compound 2) or by moieties containing additional functional groups induces significant loss of activity, possibly due to a steric hindrance effect or ability to produce undesirable hydrogen bonds, respectively. An exception in this group is derivative 4, which regardless of bulky and poly functional substituent exhibits cytotoxic activity comparable to that of compound 1. This might suggest that in this case a different type of binding to biomolecules is involved based on nucleophilic attack on the reactive terminal maleimide moiety. Sciences, (Received October 25, 1986) 
